Getting latest data loading
Home / Blog

Subscribe


 

Accendo Press Quotes – Week Ending May 19

19 May Digitallook “Equity indices are holding their rebound gains, albeit treading water since the European open, as investors weigh up recent market moves. Whilst not electing to take on more risk before the weekend, nor are they taking any more off the table. A positive statement in many ways, given the political headwinds in…

Berendsen (BRSN): Non merci!

Textile, hygiene and safety solutions group Berendsen (BRSN) is today’s winner, +25% on news of a revised offer from French workwear rental and laundry service Elis (ELIS) aimed at creating a stronger Pan-Euro leader in textile and facility services. The BRSN share price reaction is typical for a takeover offer, however, the 36-40% deal premium…

The Many Faces of Profit

Over the course of this week, some confusing corporate results from two UK 100 stalwarts have left investors bemused. Despite headline figures of rising losses, shares of one of the firms topped the daily performance charts, while rising profits at another firm have been met with a share price sell-off. What are the reasons behind…

Sophos (SOPH): Investors WannaCry with joy

Cloud-based security platform Sophos (SOPH) is topping the this morning, its shares +8.5% to trade fresh record highs in response to FY results. This makes it a trio of favourable updates this year following a 6% jump in early Feb (Q3 trading statement; strong momentum, upgraded outlook) and gains of >15% in early April (FY…

Hargreaves Lansdown: A Vanguard moment for pricing?

Vanguard’s plan to shake up the UK investment market with online low-cost direct access to its funds could spark a game-changing price war that stings brokers and fund managers alike. The US giant ($4tn AUM vs Hargreaves’ $64bn) has form in aggressively undercutting rivals to attract funds ($315bn last year) for both passive and active…

UK Index : Drugged up vs. dragged down

This week’s standout performers from the UK 100 come from opposite ends of the drug spectrum. A pharmaceutical giant benefited from early cancer drug trial news, its shares closing the week nearly 12% to the good. In stark contrast, a major producer of generic medicines gave up almost 13% after news of a likely delay…

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.